InVivoMAb anti-rat CTLA-4 (CD152)
BE0424
ApplicationsFlow Cytometry, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-rat CTLA-4 (CD152)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDWKH203
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Takatsuka N, Hasegawa A, Takamori A, et al. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax. Int Immunol. 2009,21(9):1089-100. doi: 10.1093/intimm/dxp074Read this paper
- Beyersdorf N, Gaupp S, Balbach K, et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med. 2005,202(3):445-55.Read this paper
- Elflein K, Rodriguez-Palmero M, Kerkau T, et al. Rapid recovery from T lymphopenia by CD28 superagonist therapy. Blood. 2003,102(5):1764-70.Read this paper
- Lin CH, Hünig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol. 2003,33(3):626-38.Read this paper
